Immuneering Corporation
(IMRX)
undefined
undefined%
At close: undefined
1.60
-2.44%
After-hours Dec 13, 2024, 07:58 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 59.41M | 72.64M | 74.89M | 37.09M | 13.78M |
| Short-Term Investments | 26.26M | 32.89M | 74.31M | - | - |
| Long-Term Investments | - | - | 996.56K | - | - |
| Other Long-Term Assets | 1.03M | 743.70K | 102.13K | -31.92K | -21.80K |
| Receivables | - | 12.42K | 246.04K | 500.11K | 209.94K |
| Inventory | - | 1.00 | - | - | - |
| Other Current Assets | 3.42M | 3.21M | 2.89M | 140.96K | 71.22K |
| Total Current Assets | 89.08M | 108.75M | 152.33M | 37.73M | 14.06M |
| Property-Plant & Equipment | 5.40M | 5.78M | 6.13M | 677.47K | 35.28K |
| Goodwill & Intangibles | 7.07M | 7.10M | 7.14M | - | - |
| Total Long-Term Assets | 13.50M | 13.62M | 14.37M | 691.80K | 35.28K |
| Total Assets | 102.58M | 122.37M | 166.70M | 38.42M | 14.10M |
| Account Payables | 2.11M | 3.15M | 1.39M | 1.48M | 294.95K |
| Deferred Revenue | - | - | - | - | - |
| Short-Term Debt | 300.11K | 378.72K | 274.04K | 76.32K | - |
| Other Current Liabilities | 5.43M | 4.52M | 3.97M | 698.99K | 210.35K |
| Total Current Liabilities | 7.85M | 8.05M | 5.63M | 2.26M | 505.30K |
| Long-Term Debt | 4.16M | 4.46M | 5.09M | 544.77K | 16.61M |
| Other Long-Term Liabilities | - | - | - | 58.10M | 3.51M |
| Total Long-Term Liabilities | 4.16M | 4.46M | 5.09M | 58.65M | 20.12M |
| Total Liabilities | 12.01M | 12.52M | 10.72M | 60.90M | 20.63M |
| Total Debt | 4.46M | 4.84M | 5.36M | 621.09K | 16.61M |
| Common Stock | 29.27K | 26.42K | 26.32K | 4.95K | 4.95K |
| Retained Earnings | -163.26M | -109.79M | -59.27M | -25.74M | -8.70M |
| Comprehensive Income | -778 | -30.12K | -49.01K | -58.10M | -16.61M |
| Shareholders Equity | 90.58M | 109.85M | 155.98M | -22.48M | -6.53M |
| Total Investments | 26.26M | 32.89M | 75.31M | - | - |